Clinical Trial of Diagnostic Tests and Clinical Algorithms for Dengue in Febrile Subjects in Endemic Areas in Colombia
NCT ID: NCT04063774
Last Updated: 2019-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1045 participants
INTERVENTIONAL
2016-12-27
2018-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia
NCT02570152
This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia
NCT02766088
An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil
NCT01751139
Prospective Study of Infant Dengue
NCT00377754
Diagnosis and Characterization of Dengue Fever in Children
NCT00946218
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dengue diagnostic algorithm
single arm of consecutive enrolled subjects with fever in whom the dengue diagnostic algorithms were applied by study physician and blood sample taken for hemogram and dengue reference tests (gold standard)
Dengue calculator
Clinical diagnostic algorithms of dengue generated by discrete and continuos Bayes formulas installed in a mobile device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dengue calculator
Clinical diagnostic algorithms of dengue generated by discrete and continuos Bayes formulas installed in a mobile device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
COMFANDI CAJA DE COMPENSACION DEL VALLE DEL CAUCA
UNKNOWN
SISTEMA GENERAL DE REGALIAS CASANARE, SANTANDER VALLE DEL CAUCA
UNKNOWN
RED AEDES
UNKNOWN
Lyda Osorio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lyda Osorio
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lyda Osorio, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad del Valle
Diana Ma Caicedo, MD MSc
Role: PRINCIPAL_INVESTIGATOR
Universidad del Valle
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Regional de la OrinoquĂa
Yopal, Casanare Department, Colombia
Clinica y Hospital Local de Piedecuesta
Piedecuesta, Santander Department, Colombia
COMFANDI Torres y Alameda
Cali, Valle del Cauca Department, Colombia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
144-016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.